Startup-131
Bruchsal, Germany
Makrolife Biotech developed Small Molecules to selectively target macrophages to trigger a repolarization and to induce a new immune response targeting tumor cells.
Bruchsal, Germany
Makrolife Biotech developed Small Molecules to selectively target macrophages to trigger a repolarization and to induce a new immune response targeting tumor cells.
Cologne, Germany
NeuronFab has a unique and protected approach for scalable production of human brain organoids that are cryopreservable to replace animal tests and increase effectiveness in pre-clinical research.
Aachen, Germany
PL BioScience is the global category leader for scalable cell culture supplements “the shovels!” enabling regenerative therapies “the new gold rush!”
Frankfurt, Germany
New AI-powered technology platform for the fast and efficient generation of next-generation biotherapeutics combining fully automated protein engineering with in-silico data generation and predictive and generative AI-models.
Berlin, Germany
In order to overcome health threats caused by unmet viral diseases, Belyntic develops prophylactic and therapeutic vaccines based on a distinguished nanovaccine platform.
Cologne, Germany
LTY treats the body as a system and helps people with symptoms such as fatigue, regular infections, sleep or digestive problems with individual recommendations and personalized supplements to alleviate or eliminate them. We do this based on holistic testing (DNA, gut microbiome and hormones/blood).